17.25
price down icon1.54%   -0.27
pre-market  Pre-market:  16.01   -1.24   -7.19%
loading

Xencor Inc Stock (XNCR) Latest News

pulisher
Feb 06, 2025

Xencor (XNCR) Loses -25.22% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Feb 06, 2025
pulisher
Feb 05, 2025

BlackRock, Inc. Increases Stake in Xencor Inc. - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Ratios Reveal: Breaking Down Xencor Inc (XNCR)’s Financial Health - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Xencor's SWOT analysis: biotech stock faces mixed outlook amid pipeline progress - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

Xencor Inc [XNCR] Stock sold by Insider Montgomery Alan Bruce for $0.36 million - Knox Daily

Feb 05, 2025
pulisher
Feb 04, 2025

Some Confidence Is Lacking In Xencor, Inc. (NASDAQ:XNCR) As Shares Slide 27% - Simply Wall St

Feb 04, 2025
pulisher
Feb 03, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Feb 03, 2025
pulisher
Feb 01, 2025

Xencor (NASDAQ:XNCR investor five-year losses grow to 50% as the stock sheds US$96m this past week - Yahoo Finance

Feb 01, 2025
pulisher
Feb 01, 2025

Xencor, Inc. (NASDAQ:XNCR) Short Interest Up 21.4% in January - Defense World

Feb 01, 2025
pulisher
Jan 30, 2025

Xencor: Substantial Promise, Slow Progress (NASDAQ:XNCR) - Seeking Alpha

Jan 30, 2025
pulisher
Jan 29, 2025

(XNCR) Investment Analysis - Stock Traders Daily

Jan 29, 2025
pulisher
Jan 29, 2025

Xencor Insiders Sold US$891k Of Shares Suggesting Hesitancy - Simply Wall St

Jan 29, 2025
pulisher
Jan 25, 2025

Xencor's SWOT analysis: biotech stock navigates pipeline progress amid market challenges - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

Xencor (NASDAQ:XNCR) Trading Down 3.9%Should You Sell? - MarketBeat

Jan 25, 2025
pulisher
Jan 21, 2025

Down -21.69% in 4 Weeks, Here's Why Xencor (XNCR) Looks Ripe for a Turnaround - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

JPMorgan Chase & Co. Acquires 3,635 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

After Plunging -20.27% in 4 Weeks, Here's Why the Trend Might Reverse for Xencor (XNCR) - Yahoo Finance

Jan 20, 2025
pulisher
Jan 18, 2025

Xencor (NASDAQ:XNCR) Stock Price Down 3.8%What's Next? - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Xencor Becomes Oversold (XNCR) - Nasdaq

Jan 17, 2025
pulisher
Jan 16, 2025

Xencor (XNCR) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jan 16, 2025
pulisher
Jan 15, 2025

Here's Why Xencor (XNCR) is Poised for a Turnaround After Losing -23.68% in 4 Weeks - Yahoo Finance

Jan 15, 2025
pulisher
Jan 13, 2025

Xencor Highlights Progress in Drug Development Pipeline - TipRanks

Jan 13, 2025
pulisher
Jan 10, 2025

Xencor (NASDAQ:XNCR) Trading Down 9.3%Here's Why - MarketBeat

Jan 10, 2025
pulisher
Jan 09, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat

Jan 09, 2025
pulisher
Jan 09, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

How To Trade (XNCR) - Stock Traders Daily

Jan 08, 2025
pulisher
Jan 02, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Principal Financial Group Inc. - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

Is Xencor (NASDAQ:XNCR) Using Too Much Debt? - Simply Wall St

Dec 31, 2024
pulisher
Dec 27, 2024

Geode Capital Management LLC Raises Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 27, 2024
pulisher
Dec 26, 2024

26,831 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Sanctuary Advisors LLC - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

Sanctuary Advisors LLC Takes $540,000 Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 26, 2024
pulisher
Dec 24, 2024

Barclays PLC Raises Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 24, 2024
pulisher
Dec 24, 2024

Barclays PLC Increases Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 24, 2024
pulisher
Dec 20, 2024

Intrahepatic Cholangiocarcinoma Pipeline Insights 2024: Therapies, Clinical Trials, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapeutics - The Globe and Mail

Dec 20, 2024
pulisher
Dec 20, 2024

Fmr LLC Buys 12,729 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Xencor, Inc. (NASDAQ:XNCR) Stake Increased by Jane Street Group LLC - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

State Street Corp Reduces Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

When (XNCR) Moves Investors should Listen - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 15, 2024

Xencor (NASDAQ:XNCR) Earns Overweight Rating from Analysts at Wells Fargo & Company - Defense World

Dec 15, 2024
pulisher
Dec 15, 2024

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Xencor's SWOT analysis: biotech stock balances promise and challenges - Investing.com

Dec 14, 2024
pulisher
Dec 14, 2024

Xencor's SWOT analysis: biotech stock balances promise and challenges By Investing.com - Investing.com Canada

Dec 14, 2024
pulisher
Dec 13, 2024

Wells Fargo Initiates Coverage of Xencor (XNCR) with Overweight Recommendation - MSN

Dec 13, 2024
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):